Davita Inc vs MGM Resorts International — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while MGM Resorts International trades at $30.16 (market cap $7.55B). The key difference: Davita Inc is the larger of the two by market cap, and MGM Resorts International pays a 0.03% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and MGM Resorts International for 91 Days on average.
| DVA | MGM | |
|---|---|---|
Market Cap | $11.28B | $7.55B |
Volume | 650,294 | 5,398,410 |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $50.69 |
52-Week Low | $103.87 | $30.00 |
Typical Hold Time | 113 Days | 91 Days |
Enterprise Value | $24.00B | $34.85B |
Dividend Yield | — | 0.03% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
MGM Resorts International (MGM) trades at $30.01, down 1.74% over 24 hours amid recent deal volatility. The stock is technically bearish with key support at $30, while fundamentals show revenue growth to $17.54B in 2025 but declining net margins to 2.4%. Recent news highlights a collapsed $48.30-per-share acquisition offer from Barry Diller's People Inc., contributing to negative sentiment and a 17% stock decline in 2026.
MGM's investment outlook is mixed: analyst consensus is bullish with a $49.85 price target, but risks include earnings volatility, high debt, and integration challenges from potential M&A. The stock offers value with a low P/S of 0.45, yet investors face headwinds from competitive pressures and macroeconomic sensitivity in the gaming sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →